New to The Street to Broadcast Live on Bloomberg Tonight at 6:30 PM EST as Sponsored Programming, Spotlighting BioVie (BIVI), RoadZen (RDZN), HPB, and Sustainable Innovation With Shark Tank's Kevin Harrington and Sustainable Green Team (SGTM)
NEW YORK, NY / ACCESS Newswire / February 22, 2025 / New to The Street is set to deliver an engaging broadcast on Bloomberg Television this evening at 6:30 PM EST as sponsored programming. The show will spotlight breakthrough companies and innovative market strategies that are shaping the future of healthcare, technology, and sustainable development.
A key highlight of the broadcast will be an exclusive segment with BioVie Inc. (NASDAQ:BIVI) CEO Cuong Do speaking with Jane King about the company's investigational drug bezisterim, Do revealed that the drug has shown promising clinical benefits: Parkinson's patients are experiencing improved muscle control, and Alzheimer's patients have demonstrated a 68% slowing of cognitive decline compared to placebo after just six months of treatment. Potentially the first new therapy for Parkinsons in over 50 years. The new clinical study is enrolling now go to Sunrisepd.com for more info.
In addition, the program will feature:
Roadzen Inc. (Nasdaq:RDZN): A global technology company transforming auto insurance with advanced artificial intelligence (AI), driving innovation in telematics, generative AI, and computer vision. Rohan Malhotra , the CEO of RoadZen, explained that as cars evolve into highly connected devices-essentially 'iPhones on wheels"-there's going to be a wave of innovation not just in the vehicles themselves but in all the related services. Here's what he outlined:
Expanding Ecosystem: As vehicles become more digitally advanced, areas such as identity verification, cybersecurity, in-car entertainment, and insurance will see rapid innovation.
RoadZen's AI Advantage: RoadZen uses proprietary AI algorithms to simplify these four critical areas. By doing so, they aim to:
Lower underwriting costs.
Reduce premiums.
Increase transparency in the insurance process.
In essence, RoadZen's mission is to harness AI to transform auto insurance into a more efficient, customer-friendly, and cost-effective service as our cars become smarter and more connected.
HPB: A pioneering company specializing in next-generation, solid-state batteries that are non-flammable, extremely durable, and environmentally friendly.
Sustainable Innovation Segment: Featuring Shark Tank's Kevin Harrington alongside the Sustainable Green Team (SGTM), leaders in providing sustainable, eco-friendly solutions focused on improving soil health and ecological stability.
Tune in tonight on Bloomberg Television for in-depth interviews, exclusive insights, and a look at the innovations driving advancements across multiple industries.
About BioVie Inc.
BioVie Inc. (NASDAQ:BIVI) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders (long COVID, AD and PD) and advanced liver disease. In neurodegenerative disease, the Company's drug candidate bezisterim inhibits inflammatory activation of extracellular signal-regulated kinase and the transcription factor nuclear factor-κB, and the associated neuroinflammation and insulin resistance but not ERK and NFκB homeostatic functions (e.g., insulin signaling and neuron growth and survival). Both neuroinflammation and insulin resistance are drivers of AD and PD. Persistent systematic inflammation and neuroinflammation are key features in patients with neurological symptoms of long COVID. In liver disease, the Company's Orphan drug candidate BIV201 (continuous infusion terlipressin), with FDA Fast Track status, is being evaluated and discussed with guidance received from the FDA regarding the design of Phase 3 clinical testing of BIV201 for the reduction of further decompensation in participants with liver cirrhosis and ascites. The active agent is approved in the U.S. and in about 40 countries for related complications of advanced liver cirrhosis. For more information, visit www.bioviepharma.com.
About Roadzen Inc.
Roadzen Inc. (Nasdaq:RDZN) is a global technology company transforming auto insurance using advanced artificial intelligence (AI). Thousands of clients-from the world's leading insurers and carmakers to fleets and dealerships-utilize Roadzen's technology to build new products, process claims, and enhance road safety. To learn more, visit www.roadzen.ai.
About Sustainable Green Team (SGTM)
Sustainable Green Team ($SGTM) is a leading provider of environmentally sustainable solutions focused on improving soil health and ecological stability. By addressing critical environmental challenges through innovative products and services, SGTM supports sustainable agricultural and industrial practices worldwide. For more information, visit www.sustainablegreenteam.com.
About HPB
High Performance Battery Technology GmbH is a young company specializing in the research and development of next-generation batteries with outstanding properties. The HPB Solid-State Battery is characterized by its non-flammability, extreme durability, and significantly improved environmental profile - and is already ready for series production due to an innovative manufacturing process. Based in Bonn, Germany, HPB is a wholly owned subsidiary of High Performance Battery Holding AG, based in Teufen, Switzerland, which finances its research. For additional details, visit highperformancebattery.ch.
New to The Street is a premier broadcast program with over 16 years in business, dedicated to delivering insightful commentary and in-depth analysis on emerging trends in healthcare, technology, and sustainability. Now on show number 630, the program boasts over 2.2 million YouTube subscribers and more than 600,000 followers and subscribers across X, LinkedIn (company-wide), Instagram, and Facebook, reaching over 800 million homes nationwide through real TV broadcasting every month. With exclusive interviews and breakthrough stories, New to The Street is your go-to source for market insights and innovative developments. (51) New to The Street TV - YouTube
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
43 minutes ago
- Business Insider
‘Time to Take a Pause,' Says Investor About Nvidia Stock
Nvidia (NASDAQ:NVDA) stock has roared back to life over the past two months, following a decidedly uncharacteristic drop earlier in the year. Shares have now climbed roughly 50% since hitting a post-Liberation Day low, driven by easing trade tensions, strong AI demand, and another impressive earnings report last month. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter That rebound comes despite several headwinds earlier in the year. The U.S.-China trade spat and fears of a broader pullback in AI-related capital expenditures had weighed heavily on investor sentiment. In particular, a targeted export restriction from the Trump administration on Nvidia's H20 GPUs resulted in a $4.5 billion hit during the last quarter. Still, it is hard to argue with Nvidia's stellar performance during Q1 Fiscal 2026, during which the company delivered record revenues of $44 billion, a year-over-year surge of 69%. The all-important data center segment grew at an even faster clip of 73%. While acknowledging the healthy earnings and NVDA's recovering share price, investor Johnny Zhang is not convinced that all the geopolitical hiccups are in the rearview mirror. 'I believe the 2H 2025 could bring more uncertainty, as the lagging effects of Trump's tariff policy and any setbacks on potential deals with China could create new volatility in the market,' explains the investor. Those concerns are not just theoretical. Zhang points to the unresolved H20 issue, stemming from U.S. export restrictions, as a key example. Nvidia is now expected to take an $8 billion inventory write-off as a result, and its margins are likely to decline further on a sequential basis. More broadly, the company has acknowledged it could forfeit access to a $50 billion total addressable market in China if those restrictions remain in place. Moreover, while Zhang believes that Nvidia will be able to navigate any economic slowdowns, the investor thinks there is a high possibility that the impact of the Trump tariffs will be felt during the latter part of the year. Against that backdrop, Zhang emphasizes that the recent rally in Nvidia's stock may not be sustainable without renewed visibility. He notes that further upside will hinge largely on AI spending trends in 2026, an outlook he calls 'highly uncertain.' In short, while Nvidia's fundamentals remain strong, its near-term growth path is anything but guaranteed. 'Chasing the stock's rally from here seems less compelling to me,' concludes Zhang, who gives NVDA a Hold (i.e. Neutral) rating. (To watch Zhang's track record, click here) Wall Street has a decidedly rosier view of NVDA. With 35 Buy, 4 Hold, and 1 Sell recommendations, NVDA continues to enjoy a Strong Buy consensus rating. Its 12-month average price target of $172.36 implies an upside north of 20%. (See )
Time Business News
2 hours ago
- Time Business News
Corrado Garibaldi: The Contrarian Trader Who Profits When Others Panic
In the high-stakes world of Trading Invest Celebrity Italy, where herd mentality often leads to costly mistakes, one investor has built his success on a simple but ruthless principle: When others zig, zag. Corrado Garibaldi—better known in finance circles as Lord Conrad—has carved a reputation as a maverick trader who thrives on going against the grain. His mantra? 'Buy the fear. Sell the euphoria.' The Unconventional Path to Trading Mastery Unlike Wall Street's typical Ivy League-educated financiers, Garibaldi is a self-made trader with no formal finance background. An Italian native, he entered the markets out of necessity, driven by a desire to take control of his financial future. 'I never studied economics or attended business school,' he admits. 'I learned by doing—making mistakes, refining strategies, and realizing that most people lose money because they follow the crowd.' The Contrarian Edge: Why 99.9999% of Traders Are Wrong Garibaldi's core philosophy is rooted in contrarian investing—a strategy that capitalizes on market overreactions. 'When everyone is buying, I'm selling. When panic sets in, I'm buying,' he says. 'The masses are almost always wrong at extremes. That's where the real opportunities lie.' This approach has allowed him to profit from major market swings, whether during the crypto crashes of 2022 or the AI stock frenzy of 2024. Two Sides of the Same Coin: Trader by Day, Investor by Night Garibaldi operates in two distinct modes: As a trader, he's a speed-focused tactician, scalping the Nasdaq and executing swing trades with military precision. As an investor, he's a patient wealth-builder, holding long-term positions in giants like Apple, Microsoft, and Tesla while diversifying into bonds and crypto. His portfolio strategy? 99% long-term holdings, 1% high-octane trading—a balance that maximizes growth while keeping risk in check. The Trader's Mindset: Why Psychology Beats IQ For Garibaldi, trading isn't just about charts—it's about mastering fear and greed. 'Most traders fail because they let emotions drive decisions,' he says. 'The key is to stay mechanical. Follow the plan, not the panic.' He enforces strict rules: ✔ Never risk more than 1% on a single trade ✔ Always use stop-losses ✔ Ignore hype—trade the data, not the narrative 2025 and Beyond: Adapt or Die In an era of AI-driven markets and geopolitical volatility, Garibaldi remains agile—constantly refining strategies and engaging with traders worldwide via social media. 'Markets change. If you're not learning, you're losing,' he warns. Final Word: The Slow Road to Trading Success For aspiring traders, Garibaldi's advice is refreshingly honest: 'This isn't a get-rich-quick game. Consistency beats luck. Small, smart gains compound over time—that's how real wealth is built.' Want to see his strategies in action? Visit Trading Invest Celebrity Italy. TIME BUSINESS NEWS
Yahoo
2 hours ago
- Yahoo
Virtu Financial Announces Strategic TradeOPS Collaboration, Welcoming First Joint Client
STOCKHOLM and NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (NASDAQ: VIRT), a global leader in trading and execution services, and Limina, a leading provider of cloud-native Investment Management Solutions, are proud to announce a strategic collaboration around Virtu's TradeOPS platform. Virtu's TradeOPS is a streamlined, consolidated platform that covers clients' matching, settlements and payment requirements. Designed and built specifically to automate post-trade workflows, including allocation matching and settlements, exception-based processing in TradeOPS is designed to significantly reduce settlement delays, financial penalties, and workload for buyside firms. Combined with Limina's cloud-native Order and Portfolio Management System (O/PMS), this collaboration enables buyside firms to access a fully-integrated, front-to-back workflow—seamlessly and efficiently. The collaboration has welcomed its first joint client, Cliens, who is now benefiting from Virtu's TradeOPS capabilities using DTCC-CTM via Limina's platform. 'We're excited to work with Limina to deliver an integrated and modern workflow for our TradeOPS clients,' said Pegah Esmaeili, Head of Nordic Region at Virtu. 'This integration supports our mission to deliver scalable, outsourced trading solutions by collaborating with innovative local firms like Limina—allowing us to efficiently extend our market-leading products to clients across the region.' Prem Balasubramanian, Head of Virtu's TradeOPS platform highlighted that recent changes in post-trade settlement, such as the shift to T+1 and the migration from SWIFT MT to MX, have introduced new operational challenges for buyside firms. 'By providing streamlined and effective solutions tailored to clients' needs, we can significantly reduce the operational burden and allow firms to refocus on what truly matters: managing investments and driving performance.' Prem also added, 'Working with Limina is a pleasure. The turnaround has been impressively fast, and we're looking forward to continued collaboration ahead.' "This partnership was an obvious choice to further strengthen the integration capabilities of Limina's Order Management System, not only to DTCC CTM but to all venues that tie into Virtu TradeOPS including SWIFT and more," says Kristoffer Fürst, CEO of Limina. 'The integrated solution that Virtu and Limina offer Cliens helps us extend our straight-through process, giving time to more productive tasks which adds value to our customer,' says Martin Öqvist, CEO of Cliens. About Virtu Financial, is a leading financial services firm that leverages cutting-edge technology to provide execution services and data, analytics and connectivity products to its clients and deliver liquidity to the global markets. Leveraging its global market making expertise and infrastructure, Virtu provides a robust product suite including offerings in execution, liquidity sourcing, analytics and broker-neutral, multi-dealer platforms in workflow technology. Virtu's product offerings allow clients to trade on hundreds of venues across 50+ countries and in multiple asset classes, including global equities, ETFs, foreign exchange, futures, fixed income and myriad other commodities. In addition, Virtu's integrated, multi-asset analytics platform provides a range of pre- and post-trade services, data products and compliance tools that clients rely upon to invest, trade and manage risk across global markets. About LiminaLimina's modern Investment Management Platform helps investment managers increase productivity, decrease cost and manage operational risks through a unified platform spanning the entire investment lifecycle. Founded in 2014, and headquartered in Sweden, Limina serves a growing global client base of institutional asset managers, asset owners and hedge funds with our award-winning cloud-native SaaS offering. About CliensCliens is a Swedish active fund manager focusing on delivering long-term high returns. Our funds and discretionary mandates vary from equity to fixed income and investments are made in Swedish all caps as well as Nordic and Global small caps. Contact: Investor Relations and Media RelationsAndrew Smithmedia@ in to access your portfolio
